PortfoliosLab logo

ProShares Ultra Nasdaq Biotechnology

BIB
ETF · Currency in USD
ISIN
US74347R2141
CUSIP
74347R214
Issuer
ProShares
Inception Date
Apr 7, 2010
Region
North America (U.S.)
Category
Leveraged Equities
Leveraged
2x
Expense Ratio
0.95%
Index Tracked
NASDAQ Biotechnology Index (200%)
ETF Home Page
www.proshares.com
Asset Class
Equity
Asset Class Size
Multi-Cap
Asset Class Style
Growth

BIBPrice Chart


Click Calculate to get results

BIBPerformance

The chart shows the growth of $10,000 invested in BIB on Apr 12, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $112,995 for a total return of roughly 1,029.95%. All prices are adjusted for splits and dividends.


0.00%500.00%1,000.00%20122014201620182020
1,029.95%
241.10%
S&P 500

BIBReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-0.67%
YTD-1.88%
6M11.36%
1Y68.06%
5Y12.97%
10Y25.37%

BIBMonthly Returns Heatmap


Click Calculate to get results

BIBSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ProShares Ultra Nasdaq Biotechnology Sharpe ratio is 1.67. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.000.001.002.003.004.005.0020122014201620182020
1.67

BIBDividends

ProShares Ultra Nasdaq Biotechnology granted a 0.00% dividend yield in the last twelve months, as of Apr 7, 2021. The annual payout for that period amounted to $0.00 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01
Dividend yield
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.15%

BIBDrawdowns Chart


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%20122014201620182020
-24.03%

BIBWorst Drawdowns

The table below shows the maximum drawdowns of the ProShares Ultra Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the {{portfolioName}} is 67.24%, recorded on Jun 27, 2016. It took 1152 trading sessions for the portfolio to recover.


Depth
Start
To Bottom
Bottom
To Recover
End
Total
-67.24%Jul 21, 2015237Jun 27, 20161152Jan 25, 20211389
-41.44%May 13, 201160Aug 8, 2011112Jan 18, 2012172
-39.01%Feb 26, 201433Apr 11, 2014114Sep 24, 2014147
-36.3%Apr 16, 201054Jul 1, 2010118Dec 17, 2010172
-28.79%Feb 9, 202135Mar 30, 2021
-24.73%Oct 8, 201227Nov 15, 201271Mar 1, 201398
-20.33%May 15, 201326Jun 20, 201314Jul 11, 201340
-17.74%Mar 23, 201528Apr 30, 201534Jun 18, 201562
-17.57%Oct 2, 20136Oct 9, 201332Nov 22, 201338
-16.83%Sep 25, 201414Oct 14, 20147Oct 23, 201421

BIBVolatility Chart

Current ProShares Ultra Nasdaq Biotechnology volatility is 49.69%. The chart below displays rolling 10-day Close-to-Close volatility.


0.00%50.00%100.00%150.00%200.00%20122014201620182020
49.69%

Portfolios with ProShares Ultra Nasdaq Biotechnology


Loading data...

More Tools for ProShares Ultra Nasdaq Biotechnology